Effects of sliding mode control antiretroviral drug on HIV-1 viral load

被引:0
|
作者
Ahmed, Musharif [1 ]
Zafar, Saad [1 ]
Saleem, Muhammad Aamer [2 ]
Zubair, Muhammad [1 ]
Qureshi, Ijaz Mansoor [3 ]
机构
[1] Riphah Int Univ, Fac Comp, Dept Software Engn & Comp Sci, Islamabad, Pakistan
[2] Hamdard Univ, Fac Engn Sci & Technol, Dept Elect Engn, Islamabad, Pakistan
[3] Air Univ, Fac Engn, Dept Elect Engn & Comp Engn, Islamabad, Pakistan
关键词
Sliding mode control; antiretroviral drug; drug therapy; HIV; AIDS; memetic computing; MATHEMATICAL-ANALYSIS; VIRUS DYNAMICS; INFECTION; THERAPY; HOST; ALGORITHM;
D O I
10.3906/elk-1906-65
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Human immunodeficiency virus (HIV) has devastating effects on human society. Researchers have proposed many models for the decay of CD 4(+) T cells, the growth of infected cells, and viral load. In this paper, four first-order nonlinear coupled differential equations have been considered. Four variables are CD 4(+) T cells, which are healthy, less infected cells, more infected cells capable of producing virus, and finally the viral load. Apart from the two drug therapies, protease inhibitor (PI) and reverse transcriptase inhibitor (RTI), which have already been considered in the literature, we have proposed antiretroviral drug (ARD) that works as sliding mode controller. We have used numerical methods to study the effect of RTI, PI, and ARD on healthy cells, infected cells, and the viral load. We have expressed our solutions in terms of log sigmoid functions and used memetic computing for the solution which is a hybridization of GA, a global optimizer, and sequential quadratic programming, a local optimizer. ARD, as a sliding mode controller, does help to improve the situation of the HIV patient, especially, in further reducing the viral load and also decreasing the infected cells which have the potential to produce virus. This helps in giving relief to the patient and an increase in life expectancy.
引用
收藏
页码:3111 / 3125
页数:15
相关论文
共 50 条
  • [41] Current Perspectives on HIV-1 Antiretroviral Drug Resistance
    Iyidogan, Pinar
    Anderson, Karen S.
    VIRUSES-BASEL, 2014, 6 (10): : 4095 - 4139
  • [42] Modeling the HIV-1 Antiretroviral Therapeutic Drug Interaction
    Damianopoulos, Ernest N.
    Cynamon, Michael
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (12) : 1011 - 1012
  • [43] Effect of drug interactions involving antiretroviral drugs on viral load in HIV population
    Iniesta-Navalon, Carles
    Jose Franco-Miguel, Juan
    Jose Gascon-Canovas, Juan
    Rentero-Redondo, Lorena
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2016, 23 (04) : 241 - 243
  • [44] Course of viral load throughout HIV-1 infection
    Sabin, CA
    Devereux, H
    Phillips, AN
    Hill, A
    Janossy, G
    Lee, CA
    Loveday, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (02) : 172 - 177
  • [45] CONTRIBUTION OF MATERNAL VIRAL LOAD TO HIV-1 TRANSMISSION
    ARIYOSHI, K
    WEBER, J
    WALTERS, S
    LANCET, 1992, 340 (8816): : 435 - 435
  • [46] HIV-1 viral load in blood, semen and saliva
    Vernazza, PL
    Dyer, JR
    Fiscus, SA
    Eron, JJ
    Cohen, MS
    AIDS, 1997, 11 (08) : 1058 - 1059
  • [47] Performance assessment of the new Xpert® HIV-1 viral load XC assay for quantification of HIV-1 viral loads
    Ehret, Robert
    Harb, Kudor
    Breuer, Stefan
    Obermeier, Martin
    JOURNAL OF CLINICAL VIROLOGY, 2022, 149
  • [48] Detection of HIV-1 viral load in tears of HIV/AIDS patients
    Yujing Qian
    Zunyou Wu
    Chao Chen
    Kuifang Du
    Wenbin Wei
    Infection, 2020, 48 : 929 - 933
  • [49] Detection of HIV-1 viral load in tears of HIV/AIDS patients
    Qian, Yujing
    Wu, Zunyou
    Chen, Chao
    Du, Kuifang
    Wei, Wenbin
    INFECTION, 2020, 48 (06) : 929 - 933
  • [50] Evaluation of the Xpert HIV-1 viral load assay on a wide panel of HIV-1 variants
    Gueudin, M.
    Baron, A.
    Alessandri-Gradt, E.
    Lemee, V.
    Mourez, T.
    Plantier, J. -C.
    JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S83 - S83